Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 157

1.

Breastfeeding, Cellular Immune Activation, and Myocardial Recovery in Peripartum Cardiomyopathy.

Koczo A, Marino A, Jeyabalan A, Elkayam U, Cooper LT, Fett J, Briller J, Hsich E, Blauwet L, McTiernan C, Morel PA, Hanley-Yanez K, McNamara DM; IPAC Investigators.

JACC Basic Transl Sci. 2019 Jun 24;4(3):291-300. doi: 10.1016/j.jacbts.2019.01.010. eCollection 2019 Jun.

2.

Accelerated Allograft Vasculopathy With Rituximab After Cardiac Transplantation.

Starling RC, Armstrong B, Bridges ND, Eisen H, Givertz MM, Kfoury AG, Kobashigawa J, Ikle D, Morrison Y, Pinney S, Stehlik J, Tripathi S, Sayegh MH, Chandraker A; CTOT-11 Study Investigators.

J Am Coll Cardiol. 2019 Jul 9;74(1):36-51. doi: 10.1016/j.jacc.2019.04.056.

PMID:
31272550
3.

Toll-like receptor 3 downregulation is an escape mechanism from apoptosis during hepatocarcinogenesis.

Bonnin M, Fares N, Testoni B, Estornes Y, Weber K, Vanbervliet B, Lefrançois L, Garcia A, Kfoury A, Pez F, Coste I, Saintigny P, Viari A, Lang K, Guey B, Hervieu V, Bancel B, Bartoch B, Durantel D, Renno T, Merle P, Lebecque S.

J Hepatol. 2019 Jun 18. pii: S0168-8278(19)30351-4. doi: 10.1016/j.jhep.2019.05.031. [Epub ahead of print]

PMID:
31220470
4.

Risk assessment of asbestos-cement roof sheets in Chekka, North Lebanon.

Kfoury A, Mitri G, Arab D, El Zakhem H, Aouad G.

Environ Monit Assess. 2019 May 23;191(6):391. doi: 10.1007/s10661-019-7522-0.

PMID:
31123955
5.

The impact of asymptomatic antibody-mediated rejection on outcome after heart transplantation.

Kfoury AG, Miller DV.

Curr Opin Organ Transplant. 2019 Jun;24(3):259-264. doi: 10.1097/MOT.0000000000000640.

PMID:
31090633
6.

Post-transplant outcome in patients bridged to transplant with temporary mechanical circulatory support devices.

Yin MY, Wever-Pinzon O, Mehra MR, Selzman CH, Toll AE, Cherikh WS, Nativi-Nicolau J, Fang JC, Kfoury AG, Gilbert EM, Kemeyou L, McKellar SH, Koliopoulou A, Vaduganathan M, Drakos SG, Stehlik J.

J Heart Lung Transplant. 2019 Aug;38(8):858-869. doi: 10.1016/j.healun.2019.04.003. Epub 2019 Apr 20.

PMID:
31072751
7.

The impact of asymptomatic antibody-mediated rejection on outcome after heart transplantation.

Kfoury AG, Miller DV.

Curr Opin Organ Transplant. 2019 Apr 24. doi: 10.1097/MOT.0000000000000640. [Epub ahead of print]

PMID:
31033508
8.

Novel Model to Predict Gastrointestinal Bleeding During Left Ventricular Assist Device Support.

Yin MY, Ruckel S, Kfoury AG, McKellar SH, Taleb I, Gilbert EM, Nativi-Nicolau J, Stehlik J, Reid BB, Koliopoulou A, Stoddard GJ, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O.

Circ Heart Fail. 2018 Nov;11(11):e005267. doi: 10.1161/CIRCHEARTFAILURE.118.005267. Erratum in: Circ Heart Fail. 2019 Feb;12(2):e000034.

PMID:
30571195
9.

Early immune biomarkers and intermediate-term outcomes after heart transplantation: Results of Clinical Trials in Organ Transplantation-18.

Stehlik J, Armstrong B, Baran DA, Bridges ND, Chandraker A, Gordon R, De Marco T, Givertz MM, Heroux A, Iklé D, Hunt J, Kfoury AG, Madsen JC, Morrison Y, Feller E, Pinney S, Tripathi S, Heeger PS, Starling RC.

Am J Transplant. 2019 May;19(5):1518-1528. doi: 10.1111/ajt.15218. Epub 2019 Jan 22.

PMID:
30549425
10.

Microvascular Loss and Diastolic Dysfunction in Severe Symptomatic Cardiac Allograft Vasculopathy.

Daud A, Xu D, Revelo MP, Shah Z, Drakos SG, Dranow E, Stoddard G, Kfoury AG, Hammond MEH, Nativi-Nicolau J, Alharethi R, Miller DV, Gilbert EM, Wever-Pinzon O, McKellar SH, Afshar K, Khan F, Fang JC, Selzman CH, Stehlik J.

Circ Heart Fail. 2018 Aug;11(8):e004759. doi: 10.1161/CIRCHEARTFAILURE.117.004759.

PMID:
30354559
11.

Cardiac Rotational Mechanics As a Predictor of Myocardial Recovery in Heart Failure Patients Undergoing Chronic Mechanical Circulatory Support: A Pilot Study.

Bonios MJ, Koliopoulou A, Wever-Pinzon O, Taleb I, Stehlik J, Xu W, Wever-Pinzon J, Catino A, Kfoury AG, Horne BD, Nativi-Nicolau J, Adamopoulos SN, Fang JC, Selzman CH, Bax JJ, Drakos SG.

Circ Cardiovasc Imaging. 2018 Apr;11(4):e007117. doi: 10.1161/CIRCIMAGING.117.007117.

12.

AMPK promotes survival of c-Myc-positive melanoma cells by suppressing oxidative stress.

Kfoury A, Armaro M, Collodet C, Sordet-Dessimoz J, Giner MP, Christen S, Moco S, Leleu M, de Leval L, Koch U, Trumpp A, Sakamoto K, Beermann F, Radtke F.

EMBO J. 2018 Mar 1;37(5). pii: e97673. doi: 10.15252/embj.201797673. Epub 2018 Feb 12.

13.

Clinical and histopathological effects of heart failure drug therapy in advanced heart failure patients on chronic mechanical circulatory support.

Catino AB, Ferrin P, Wever-Pinzon J, Horne BD, Wever-Pinzon O, Kfoury AG, McCreath L, Diakos NA, McKellar S, Koliopoulou A, Bonios MJ, Al-Sarie M, Taleb I, Dranow E, Fang JC, Drakos SG.

Eur J Heart Fail. 2018 Jan;20(1):164-174. doi: 10.1002/ejhf.1018. Epub 2017 Nov 1.

14.

Circulating T-Cell Subsets, Monocytes, and Natural Killer Cells in Peripartum Cardiomyopathy: Results From the Multicenter IPAC Study.

McTiernan CF, Morel P, Cooper LT, Rajagopalan N, Thohan V, Zucker M, Boehmer J, Bozkurt B, Mather P, Thornton J, Ghali JK, Hanley-Yanez K, Fett J, Halder I, McNamara DM; IPAC Investigators.

J Card Fail. 2018 Jan;24(1):33-42. doi: 10.1016/j.cardfail.2017.10.012. Epub 2017 Oct 24.

15.

Implementation of Real-Time Assessment of Patient-Reported Outcomes in a Heart Failure Clinic: A Feasibility Study.

Stehlik J, Rodriguez-Correa C, Spertus JA, Biber J, Nativi-Nicolau J, Zickmund S, Steinberg BA, Peritz DC, Walker A, Hess J, Drakos SG, Kfoury AG, Fang JC, Selzman CH, Hess R.

J Card Fail. 2017 Nov;23(11):813-816. doi: 10.1016/j.cardfail.2017.09.009. Epub 2017 Oct 2.

PMID:
28982635
16.

Regional myocardial structural characteristics in ischemic and non-ischemic cardiomyopathy: Left ventricle versus right and apex versus base.

Diakos NA, Passi S, Taleb I, Kfoury AG, Drakos SG.

J Heart Lung Transplant. 2018 Jan;37(1):166-169. doi: 10.1016/j.healun.2017.07.027. Epub 2017 Jul 29. No abstract available.

PMID:
28890255
17.

Clinical Decision Support to Efficiently Identify Patients Eligible for Advanced Heart Failure Therapies.

Evans RS, Kfoury AG, Horne BD, Lloyd JF, Benuzillo J, Rasmusson KD, Roberts C, Lappé DL.

J Card Fail. 2017 Oct;23(10):719-726. doi: 10.1016/j.cardfail.2017.08.449. Epub 2017 Aug 16.

PMID:
28821391
18.

Health characteristics of heart transplant recipients surviving into their 80s.

Tabachnick DR, Bowen ME, Stehlik J, Kfoury AG, Caine WT, Selzman CH, McKellar SH; Utah Cardiac Transplant Program (UCTP).

J Surg Res. 2017 Aug;216:99-102. doi: 10.1016/j.jss.2017.04.021. Epub 2017 May 6.

PMID:
28807220
19.

Favorable Effects on Pulmonary Vascular Hemodynamics with Continuous-Flow Left Ventricular Assist Devices Are Sustained 5 Years After Heart Transplantation.

Saidi A, Selzman CH, Ahmadjee A, Al-Sarie M, Snow GL, Wever-Pinzon O, Alharethi R, Reid B, Stehlik J, Kfoury AG, Bader F.

ASAIO J. 2018 Jan/Feb;64(1):38-42. doi: 10.1097/MAT.0000000000000614.

PMID:
28661912
20.

Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning.

Diakos NA, Navankasattusas S, Abel ED, Rutter J, McCreath L, Ferrin P, McKellar SH, Miller DV, Park SY, Richardson RS, Deberardinis R, Cox JE, Kfoury AG, Selzman CH, Stehlik J, Fang JC, Li DY, Drakos SG.

JACC Basic Transl Sci. 2016 Oct;1(6):432-444. doi: 10.1016/j.jacbts.2016.06.009. Epub 2016 Oct 31.

Supplemental Content

Loading ...
Support Center